Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revance Therapeutics (RVNC)
NASDAQ:RVNC
Holding RVNC?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 59.88M | $ 65.39M | $ 51.94M | $ 69.80M | $ 56.78M |
| Gross Profit | $ 42.25M | $ 47.75M | $ 37.02M | $ 52.33M | $ 37.36M |
| EBIT | $ -30.10M | $ -32.22M | $ -44.27M | - | $ -135.78M |
| EBITDA | $ -26.85M | $ -28.66M | $ -42.89M | - | $ -133.66M |
| Net Income Common Stockholders | $ -38.12M | $ -37.47M | $ -53.15M | $ -55.76M | $ -141.18M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 184.08M | $ 232.24M | $ 277.07M | $ 253.91M | $ 300.25M |
| Total Assets | $ 461.56M | $ 494.80M | $ 508.12M | $ 478.45M | $ 532.49M |
| Total Debt | $ 483.45M | $ 491.64M | $ 475.78M | $ 478.43M | $ 487.90M |
| Net Debt | $ 299.37M | $ 259.39M | $ 198.71M | $ 224.52M | $ 187.65M |
| Total Liabilities | $ 624.59M | $ 624.54M | $ 606.79M | $ 630.06M | $ 638.69M |
| Stockholders Equity | $ -163.03M | $ -160.75M | $ -98.67M | $ -151.60M | $ -106.20M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -41.15M | $ -41.60M | $ -67.65M | - | $ -55.47M |
| Operating Cash Flow | $ -41.09M | $ -41.13M | $ -65.94M | $ -42.73M | $ -50.96M |
| Investing Cash Flow | $ 23.29M | $ -6.89M | $ -31.71M | $ 2.37M | $ 51.59M |
| Financing Cash Flow | $ -6.09M | $ -3.41M | $ 92.83M | $ -1.63M | $ 37.46M |